Ad is loading...
MRLOX
Price
$18.04
Change
-$0.06 (-0.33%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

MRLOX vs RLEFX

Header iconMRLOX vs RLEFX Comparison
Open Charts MRLOX vs RLEFXBanner chart's image
BlackRock Global Allocation R
Price$18.04
Change-$0.06 (-0.33%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
MRLOX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MRLOX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRLOX is a Buy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. MRLOX (16.8B). RLEFX pays higher dividends than MRLOX: RLEFX (2.42) vs MRLOX (0.75). MRLOX was incepted earlier than RLEFX: MRLOX (22 years) vs RLEFX (9 years). MRLOX (174.00) and RLEFX (171.00) have comparable annual turnover. MRLOX has a lower initial minimum investment than RLEFX: MRLOX (100) vs RLEFX (250). RLEFX annual gain was more profitable for investors over the last year : 21.09 vs. MRLOX (11.48). RLEFX return over 5 years is better than : 35.95 vs. MRLOX (-0.66).
MRLOXRLEFXMRLOX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years9 years-
Gain YTD5.27914.21137%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets16.8B236B7%
Annual Yield % from dividends0.752.4231%
Returns for 1 year11.4821.0954%
Returns for 3 years-12.3810.95-113%
Returns for 5 years-0.6635.95-2%
Returns for 10 years-9.92N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology